Taysha Gene Therapies, Inc. (TSHA)
5.49
-0.05
(-0.90%)
USD |
NASDAQ |
May 22, 16:00
5.49
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Assets (Quarterly) : 300.35M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| United Therapeutics Corp. | 6.714B |
| TG Therapeutics, Inc. | 1.529B |
| ADMA Biologics, Inc. | 665.18M |
| UroGen Pharma Ltd. | 253.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 88.41M |
| Shareholders Equity (Quarterly) | 211.94M |
| Debt to Equity Ratio | 0.3247 |
| Current Ratio | 14.03 |
| Net Debt Paydown Yield | -0.08% |